Capital Startup Venture Capital Westlake Village 
socalTECH
DECEMBER 15, 2020
Los Angeles-based life sciences investor Westlake Village BioPartners announced today that it has raised two new venture capital funds, worth a total of $500M, for its investments in biotech companies. The venture investor says it has now raised more than $820M in total for its investments.
socalTECH
MARCH 9, 2015
CoverHound , a startup which offers up an online marketplace for auto, motorcycle, home, and renter''s insurance, said this morning that it has doubled its space in Southern California, as part of a new funding round for the company. READ MORE>>.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
socalTECH
DECEMBER 15, 2020
Los Angeles-based ACELYRIN , a new startup biopharma company, announced this morning that it has raised a Series A funding. The funding came from Westlake Village BioPartners. Beth Seidenberg, MD, co-founding managing director of Westlake Village BioPartners, has joined ACELYRIN's board as part of the funding.
socalTECH
APRIL 29, 2021
Thousand Oaks-based Capsida Biotherapeutics, a new biotechnology company focused on using adeno-associated virus (AAV) engineering and cargo development platform to develop tissue-targeted gene therapies for multiple types of diseases, has uncloaked from stealth mode, saying it has raised $140M in total capital.
Xconomy
SEPTEMBER 5, 2018
But a new venture capital firm led by industry veterans is trying to cast the City of Angels in a new light. Westlake Village BioPartners is launching today with $350 million in committed capital. Harper will start with Westlake in January after retiring from Amgen.
socalTECH
SEPTEMBER 22, 2015
CoverHound , which has offices in Westlake Village, and is also one of the portfolio firms of Los Angeles-based venture investor Core Innovation Capital , has raised $33.3M Los Angeles investor Core Innovation Capital, which makes investments in fintech startups, also invested in CoverHound's prior round.
socalTECH
JULY 5, 2017
Westlake Village-based Sienna Biopharmaceuticals , a startup biopharmaceuticals firm developing products for the medical dermatology and aesthetics market, has filed for an IPO. Sienna said it is hoping to raised up to $74.8M Morgan, Cowen, and BMO Capital Markets. Morgan, Cowen, and BMO Capital Markets.
Expert insights. Personalized for you.
113 
Let's personalize your content